These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 9528183

  • 21. [The treatment of pre-malignant hyperplasias of the endometrium with progesterone-carrying intra-uterine devices (author's transl)].
    Sievers S, Dallenbach-Hellweg G, Schaude H.
    Geburtshilfe Frauenheilkd; 1979 May; 39(5):389-92. PubMed ID: 456861
    [Abstract] [Full Text] [Related]

  • 22. Precursors of endometrial clear cell carcinoma.
    Fadare O, Liang SX, Ulukus EC, Chambers SK, Zheng W.
    Am J Surg Pathol; 2006 Dec; 30(12):1519-30. PubMed ID: 17122507
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action.
    Kumar NS, Richer J, Owen G, Litman E, Horwitz KB, Leslie KK.
    Cancer Res; 1998 May 01; 58(9):1860-5. PubMed ID: 9581825
    [Abstract] [Full Text] [Related]

  • 25. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA, Blake JM, Crosignani PG.
    Hum Reprod Update; 2005 May 01; 11(6):545-60. PubMed ID: 16150813
    [Abstract] [Full Text] [Related]

  • 26. Dual-specificity phosphatase 6 predicts the sensitivity of progestin therapy for atypical endometrial hyperplasia.
    Zhang H, Yan L, Bai Y, Li C, Guo Q, Wang C, Zhao X, Li M.
    Gynecol Oncol; 2015 Mar 01; 136(3):549-53. PubMed ID: 25451692
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec 01; 15(6):453-65. PubMed ID: 11826770
    [Abstract] [Full Text] [Related]

  • 29. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Wheeler DT, Bristow RE, Kurman RJ.
    Am J Surg Pathol; 2007 Jul 01; 31(7):988-98. PubMed ID: 17592264
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens].
    Ivanov S.
    Akush Ginekol (Sofiia); 2005 Jul 01; 44(4):18-20. PubMed ID: 16028373
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.
    Yang YC, Wu CC, Chen CP, Chang CL, Wang KL.
    Gynecol Oncol; 2005 Nov 01; 99(2):287-93. PubMed ID: 16051341
    [Abstract] [Full Text] [Related]

  • 37. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.
    Arnett-Mansfield RL, deFazio A, Wain GV, Jaworski RC, Byth K, Mote PA, Clarke CL.
    Cancer Res; 2001 Jun 01; 61(11):4576-82. PubMed ID: 11389093
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Histopathologic aspects in endometrium dysplasias.
    Florescu M, Simionescu C, Comănescu V, Plesea E.
    Rom J Morphol Embryol; 1996 Jun 01; 42(1-2):101-7. PubMed ID: 9038393
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.